1-2 of 2
for the FRALLE group
Close
Sort by
Journal Articles

A Plateau after 30 Months of Follow-Up in B -Lineage Childhood Acute Lymphoblastic Leukemia (ALL) with t(1;19)(q23;p13)/E2A-PBX1?.

André Baruchel, MD, Sylvie Chevret, MD, PhD, Anne Auvrignon, MD, Paola Ballerini, MD, PhD, Gérard Michel, MD, Jean Gabert, MD, PhD, Christiane Vermylen, MD, Yves Perel, MD, Chrystèle Bilhou-Nabera, MD, Odile Lejars, MD, Claudine Schmitt, MD, Pierre Jonveaux, MD, PhD, Jean Soulier, MD, PhD, Jacqueline Vandenaker, MD, Marie-Françoise Auclerc, MD, Thierry Leblanc, MD, Guy Leverger, MD, for the FRALLE Group
Journal: Blood
Blood (2005) 106 (11): 1441.
https://doi.org/10.1182/blood.V106.11.1441.1441
Published: 2005
Journal Articles

Evaluation of Minimal Residual Disease (MRD) by Quantification of TEL-AML1 Transcripts Is a Powerful Prognostic Tool in Children with T(12;21) Positive Acute Lymphoblastic Leukemia (ALL).

Jean-Michel Cayuela, PhD, Paola Ballerini, PhD, Marina Romeo, PhD, Vahid Asnafi, PhD, Marie-Francoise Auclerc, MD, Xavier Fund, PhD, Eric Delabesse, PhD, Christian Bastard, PhD, Jean Gabert, PhD, Jean-Pierre Vanier, MD, Odile Lejars, MD, Mariane Debre, MD, Brigitte Pautard, MD, Gerard Michel, MD, Thierry Leblanc, MD, Guy Leverger, MD, Sylvie Chevret, PhD, Elisabeth Macintyre, PhD, Andre Baruchel, MD, for the FRALLE group
Journal: Blood
Blood (2004) 104 (11): 322.
https://doi.org/10.1182/blood.V104.11.322.322
Published: 2004